|
2025
|
Invention
|
Isoxazoline compound and use thereof. Provided in the present application are an isoxazoline comp... |
|
|
Invention
|
Pharmaceutical composition containing anti-gpc3/cd3 bispecific antibody. Provided is a pharmaceut... |
|
|
Invention
|
Use of kras inhibitor in preparing drug for treating advanced solid tumor. The present invention ... |
|
|
Invention
|
Composition comprising aflibercept and variant thereof, related method therefor, and use thereof.... |
|
|
Invention
|
Polymorph of usp1 inhibitor. Provided in the present invention are a polymorph and salt form of a... |
|
2024
|
Invention
|
Stable pharmaceutical composition of anti-pd-1 antibody. Provided is a stable pharmaceutical comp... |
|
|
Invention
|
Composition comprising aflibercept and a variant thereof, and related methods and uses.
Provided... |
|
|
Invention
|
Stable pharmaceutical composition of mixed antibodies. Provided is a pharmaceutical composition c... |
|
|
Invention
|
Polypeptide having multi-agonistic activity and use thereof. Provided is a triple-agonist polypep... |
|
|
Invention
|
Irna composition and use method thereof. An iRNA composition and a use method thereof. |
|
|
Invention
|
High drug-loading fulvestrant pharmaceutical composition and preparation method thereof.
The pre... |
|
|
Invention
|
Pharmaceutical preparation of anti-human ccr8 monoclonal antibody and use thereof. Provided are a... |
|
|
Invention
|
Composition comprising aflibercept and a variant thereof, and related methods and uses. Provided ... |
|
|
Invention
|
Use of 3clpro inhibitor in preparation of drug for treating diseases caused by feline coronavirus... |
|
|
Invention
|
Use of tyrosine kinase inhibitor. Provided in the present application are the use of a compound r... |
|
|
Invention
|
Crystal form and use of parp 7 inhibitor and salt thereof. A crystal form of a compound of formul... |
|
|
Invention
|
Preparation method for parp7 inhibitor. Provided is a preparation method for a PARP7 inhibitor. T... |
|
2023
|
Invention
|
Inhalation spray of semaglutide and preparation method thereof.
The present invention provides a... |
|
|
Invention
|
Stable high-concentration self-buffering pharmaceutical composition. Provided is a stable high-co... |
|
|
Invention
|
Use of egfr kinase inhibitor. Provided is use of a compound represented by formula (I) or a pharm... |
|
|
Invention
|
Cdk inhibitor and polymorph of phosphate thereof. The present application provides a polymorph of... |
|
|
Invention
|
Crystal form of spirocyclic amine aryl phosphorus oxide compound and preparation method therefor.... |
|
|
Invention
|
Pharmaceutical composition comprising anti-ctla4 and anti-pd1 antibody mixture and therapeutic us... |
|
|
Invention
|
Pharmaceutical composition comprising mixed antibody of anti-ctla4 and anti-pd1 and therapeutic u... |
|
|
Invention
|
Pharmaceutical composition containing mixed antibody of anti-ctla4 and anti-pd1 and therapeutic u... |
|
|
Invention
|
Pharmaceutical composition comprising mixed antibodies anti-ctla4 and anti-pd1 and therapeutic us... |
|
|
Invention
|
Drug composition of spiro aryl phosphine oxide and anti-vegf antibody. Disclosed in the present i... |
|
|
Invention
|
Pharmaceutical combination of spirocyclic aryl phosphorus oxide and anti-egfr antibody. Disclosed... |
|
2022
|
Invention
|
Polymorph of egfr inhibitor. Provided is a compound of formula (A), N-(6-((5-bromo-2-((6-isopropy... |
|
|
Invention
|
Use of tricyclic compound. The present invention provides a use of a compound represented by form... |
|
|
Invention
|
Pharmaceutical composition, and preparation method therefor and application thereof.
A pharmaceu... |
|
|
Invention
|
Pharmaceutical composition, and preparation method therefor and application thereof. A pharmaceut... |
|
|
Invention
|
Crystal form of entrectinib and preparation method therefor.
Crystal forms of Entrectinib and pr... |
|
|
Invention
|
Crystal form of entrectinib and preparation method therefor. The present invention relates to a c... |
|
2021
|
Invention
|
Adcc-enhanced humanized antibody for claudin 18a2 and application thereof. Provided are an anti-C... |
|
|
Invention
|
High-concentration anti-her2 antibody preparation and use thereof. The present invention relates ... |
|
|
Invention
|
Tricyclic compounds as egfr inhibitors.
Provided are a class of compounds, represented by formul... |
|
|
Invention
|
Tricyclic compounds as egfr inhibitors. Provided are a class of compounds, represented by formula... |
|
|
Invention
|
Novel aminopyrimidine egfr inhibitor.
The present invention provides a novel aminopyrimidine com... |
|
|
Invention
|
Novel aminopyrimidine egfr inhibitor. The present invention provides a novel aminopyrimidine comp... |
|
2020
|
Invention
|
Biaryl compound as pan-raf kinase inhibitor.
Disclosed is a biarylamide compound as a Pan-RAF ki... |
|
|
Invention
|
Antibody against claudin 18a2 and use thereof. Provided are an anti-CLDN18.2 antibody or an antig... |
|
2019
|
P/S
|
Medicines for human purposes; pharmaceutical preparations;
vitamin preparations; drugs for medic... |
|
|
P/S
|
Anti-infective preparations for veterinary purposes; anti-infectives; anti-inflammatory ointments... |
|
|
P/S
|
Medicines for the prevention and treatment of cancer, nervous system diseases, cardio-cerebrovasc... |
|
|
Invention
|
Anti-human pd-1 monoclonal antibody formulation, combined medicament and use thereof. Disclosed i... |
|
2018
|
Invention
|
Crystal form of β-lactamase inhibitor and preparation method therefor. Disclosed in the present d... |
|
|
Invention
|
Polymorphic form of compound, preparation method and use thereof. The present disclosure relates ... |
|
2017
|
Invention
|
Β-lactamase inhibitors. Disclosed in the present invention is a type of novel β-lactamase inhibit... |
|
2016
|
P/S
|
Chemicals used in industry; chemicals for science; Chemicals used in photography; Chemicals for u... |
|
|
Invention
|
Crystal form, preparation method and intermediate of dihydropyrido ring compound. Disclosed in th... |
|
2009
|
P/S
|
[ Pharmaceutical preparations, namely, injections, capsules and tablets for use in ophthalmology,... |
|
|
P/S
|
Injections; tablets; biochemical medicines; medicines for
human purposes; drugs for medical purp... |
|
|
P/S
|
Nausea treatment medications; antibiotics; cough treatment medication; eye washes; pharmaceutical... |
